Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2024-08-16 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides dates and types of meetings. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content. The document is essentially a regulatory announcement about upcoming investor meetings. Given its short length (1276 characters) and nature, it fits best as a Regulatory Filing (RNS) rather than a full investor presentation or report.
2024-08-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled Analyst / Institutional Investor Meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, detailed presentations, or reports. It is an announcement of an upcoming investor meeting rather than the meeting materials or transcript itself. The document length is only 1307 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-08-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on August 13, 2024, discussing the audited financial results for the quarter ended June 30, 2024. It includes detailed management commentary on financial performance, segment-wise revenue, EBITDA, profit margins, subsidiary performance, R&D spending, and answers to analyst questions. The content is a full text transcript of an earnings conference call, which matches the definition of a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive financial data and management discussion, confirming it is not merely an announcement or summary but a full transcript.
2024-08-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of a conference call discussing the unaudited financial results for the quarter ended June 30, 2024. It mentions that the transcript will be provided later. The document does not contain the transcript itself or detailed financial data, but rather an announcement about the conference call recording and future transcript availability. This fits the category of a Call Transcript (CT) announcement, but since the transcript is not included, it is not the transcript itself. The document is short (1697 characters) and serves as an announcement rather than the full transcript. Therefore, it should be classified as Regulatory Filings (RNS), which is the fallback for announcements and notices that do not fit other categories.
2024-08-13 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the newspaper publication of an extract of un-audited consolidated financial results for the quarter ended June 30, 2024. It references compliance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document includes a notice about the publication of financial results extract in newspapers and mentions the quarter-end date, indicating it is related to quarterly financial results. The document is about the publication of an extract of financial results, not the full interim or quarterly report itself. It is a formal announcement of the publication of financial results extract, which is typically a Regulatory Filing (RNS) rather than the full Interim/Quarterly Report (IR). The document length is 15,000 characters, but the content is primarily an announcement of the newspaper publication of the extract, not the full report with substantive financial data and analysis. Therefore, it fits best under Regulatory Filings (RNS).
2024-08-12 English
Press Release
Regulatory Filings
2024-08-10 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.